How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/pre-b-cell-acute-lymphoblastic-leukemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Pre B-cell acute lymphoblastic leukemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pre B-cell acute lymphoblastic leukemia (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Pre B-cell acute lymphoblastic leukemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Besponsa	inotuzumab-ozogamicin	Pfizer	Antibody-drug conjugate (ADC)	CD22		2017-01-01
Blincyto	blinatumomab	Amgen	Bispecific CD19-directed CD3-directed T Cell Engager	B-lymphocyte antigen CD19		2014-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Amgen · 1 drug in Pre B-cell acute lymphoblastic leukemia
Pfizer · 1 drug in Pre B-cell acute lymphoblastic leukemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Pre B-cell acute lymphoblastic leukemia:

Cite this brief

Drug Landscape (2026). Pre B-cell acute lymphoblastic leukemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pre-b-cell-acute-lymphoblastic-leukemia. Accessed 2026-06-10.

Pre B-cell acute lymphoblastic leukemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing